Iboga and ibogaine, without the sales pitch
Independent, source-checked information on the plant, the science, the risks, the law, and the Bwiti tradition it comes from. No clinic referrals, no affiliate links.
- 9sections
- 17jurisdictions
- 161sources cited
Sections
Compare
Ibogaine set beside ayahuasca, ketamine, psilocybin, methadone and buprenorphine. Direct answers, then the table, then the detail.
Experiences
What an ibogaine experience is actually like, hour by hour. Verified accounts, microdosing, integration, and the parts nobody advertises.
The plant
Tabernanthe iboga: what the shrub is, where it grows, which part holds the alkaloid, and how it differs from ibogaine itself.
Legality
Ibogaine's legal status runs from prohibited to prescribable. Twenty-six jurisdictions, each with the instrument behind it and whether we read it.
Science
What the peer-reviewed literature establishes about ibogaine, what it only suggests, and what remains untested. Plain language, primary sources.
News
Legislation, clinical trials and the companies involved. Weekly briefs plus standing files on the stories that keep moving.
Safety
Cardiac risk, contraindications, interactions and dosing. Every page in this section is reviewed by a clinician and dated.
Tradition
Iboga before it was ibogaine: the Bwiti religion, initiation, Gabon's national heritage plant, and the conservation questions that follow.
Treatment
How treatment works, what it costs, how to judge a clinic and when to walk away. No referrals, no rankings, no affiliate links.
Recently published
Ibogaine in Arizona
Arizona put $5 million into an ibogaine trial in traumatic brain injury through its 2025 budget. What the grant requires, and what it does not.
Ibogaine in Australia
Ibogaine is a Schedule 4 prescription-only medicine in Australia. Widely reported as legal, which is not what Schedule 4 means.
Ibogaine in Brazil
Brazil's regulator says ibogaine treatments are unregulated. A São Paulo council said hospitals only. The federal government says no.
What this site is
An independent information site about iboga and ibogaine. Not a clinic, not a vendor, not an advocacy group. It is funded by its founders, carries no advertising and no affiliate links, and refers no one to any provider.
The whole subject is covered in one place, in the complete guide. Everything else on the site develops one part of it.
Read the complete guide →
How we treat it
Primary sources first: statutes, trial registries, peer-reviewed research. Clinic marketing is the subject of our reporting, never a source for it. Where the evidence is thin, the page says so instead of rounding it up.
Legal pages carry the date their statute was last checked. Medical pages carry the name of the physician who reviewed them and the date they did. Both go stale in public rather than quietly.
How we source →Who writes it
Every page names its author. Safety, science and treatment pages also name the clinician who reviewed them, matched to the subject: a cardiologist for cardiac risk, an addiction specialist for withdrawal and interactions.
The contributors →
Where ibogaine stands, country by country
Start here
One subject, covered in one place
The complete guide runs from the plant to the law in a single read. Everything else on the site develops one part of it, with its sources shown and the date we last checked them.